New CFO..is a seller. He has a history of selling off companies. He will also try to sell Numinus... hopefully at many multiples of its current valuation. However, given that Numinus is a market leader, who will buy the firm? Given we are just in the top of the first inning with MDMA/psylocibin wave, how about we wait for the wave to swell before finding a suitor?
Maybe at $2/share... or $5/share